Neuren Pharmaceuticals Annual Report 2025

TWENTY LARGEST HOLDERS OF QUOTED ORDINARY SHARES Number of ordinary shares % of issued share capital 1 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED 22,145,477 17.50 2 CITICORP NOMINEES PTY LIMITED 13,834,099 10.93 3 J P MORGAN NOMINEES AUSTRALIA PTY LIMITED 10,413,515 8.23 4 BNP PARIBAS NOMS PTY LTD 5,238,479 4.14 5 CAMERON RICHARD PTY LTD 3,914,900 3.09 6 STUART ANDREW PTY LTD 2,814,100 2.22 7 SMITHLEY SUPER PTY LTD 1,577,000 1.25 8 LINWIERIK SUPER PTY LTD 1,560,000 1.23 9 BNP PARIBAS NOMINEES PTY LTD 1,520,378 1.20 10 JONATHAN PILCHER 1,500,000 1.19 11 SHARESIES AUSTRALIA NOMINEE PTY LIMITED 1,323,965 1.05 12 SOUTHERN CAPITAL LIMITED 1,103,947 0.87 13 MJHFT PTY LTD 900,000 0.71 14 ESSEX CASTLE LIMITED 843,731 0.67 15 FIRST COLBYCO PTY LTD 800,000 0.63 16 BNP PARIBAS NOMINEES PTY LTD 714,490 0.56 17 DR ROBIN LANCE CONGREVE 641,637 0.51 18 EMANCIPAYTE PTY LTD 463,151 0.37 19 BNP PARIBAS NOMINEES PTY LTD 463,066 0.37 20 MR HE ZHAO 424,600 0.34 Total 72,196,535 57.06 Balance of share register 54,337,091 42.94 Total ordinary shares quoted on ASX 126,533,626 100.00 SUBSTANTIAL SECURITY HOLDERS The following have filed substantial holding notifications based on the last notice lodged on the ASX: Number held Percentage The Vanguard Group, Inc. and its controlled entities1 6,492,295 5.023% State Street Corporation and subsidiaries2 6,412, 618 5.01% 1 As disclosed in substantial holder notice dated 11 March 2025. 2 As disclosed in substantial holder notice dated 5 May 2025. ADDITIONAL INFORMATION CONTINUED Neuren Pharmaceuticals Limited Annual Report 2025 64

RkJQdWJsaXNoZXIy MjE2NDg3